Soleno Therapeutics (SLNO) Gross Profit: 2013-2024
Historic Gross Profit for Soleno Therapeutics (SLNO) over the last 5 years, with Dec 2024 value amounting to -$231,000.
- Soleno Therapeutics' Gross Profit rose 16.33% to -$41,000 in Q2 2017 from the same period last year, while for Jun 2017 it was $6,482, marking a year-over-year decrease of 94.25%. This contributed to the annual value of -$231,000 for FY2024, which is N/A change from last year.
- Per Soleno Therapeutics' latest filing, its Gross Profit stood at -$231,000 for FY2024, which was down 294.75% from -$58,518 recorded in FY2016.
- In the past 5 years, Soleno Therapeutics' Gross Profit registered a high of -$231,000 during FY2024, and its lowest value of -$231,000 during FY2024.
- In the last 1 years, Soleno Therapeutics' Gross Profit had a median value of -$231,000 in 2024 and averaged -$231,000.